Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.22 HKD
−168.82 M HKD
168.82 M HKD
410.92 M
About Jacobio Pharmaceuticals Group Co., Ltd.
Sector
Industry
CEO
Yin Xin Wang
Website
Headquarters
Beijing
Founded
2018
ISIN
KYG4987A1094
FIGI
BBG00YGD1105
Jacobio Pharmaceuticals Group Co., Ltd. is an investment holding company, which engages in the research and development of pharmaceutical products. The company was founded on June 01, 2018 and is headquartered in Beijing, China.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 1167 is 10.17 HKD — it has increased by 1.10% in the past 24 hours. Watch Jacobio Pharmaceuticals Group Co., Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange Jacobio Pharmaceuticals Group Co., Ltd. stocks are traded under the ticker 1167.
1167 stock has risen by 20.36% compared to the previous week, the month change is a 20.21% rise, over the last year Jacobio Pharmaceuticals Group Co., Ltd. has showed a 481.14% increase.
We've gathered analysts' opinions on Jacobio Pharmaceuticals Group Co., Ltd. future price: according to them, 1167 price has a max estimate of 5.30 HKD and a min estimate of 5.30 HKD. Watch 1167 chart and read a more detailed Jacobio Pharmaceuticals Group Co., Ltd. stock forecast: see what analysts think of Jacobio Pharmaceuticals Group Co., Ltd. and suggest that you do with its stocks.
1167 reached its all-time high on Feb 4, 2021 with the price of 25.35 HKD, and its all-time low was 1.20 HKD and was reached on Dec 24, 2024. View more price dynamics on 1167 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1167 stock is 5.60% volatile and has beta coefficient of 1.00. Track Jacobio Pharmaceuticals Group Co., Ltd. stock price on the chart and check out the list of the most volatile stocks — is Jacobio Pharmaceuticals Group Co., Ltd. there?
Today Jacobio Pharmaceuticals Group Co., Ltd. has the market capitalization of 6.40 B, it has decreased by −2.76% over the last week.
Yes, you can track Jacobio Pharmaceuticals Group Co., Ltd. financials in yearly and quarterly reports right on TradingView.
Jacobio Pharmaceuticals Group Co., Ltd. is going to release the next earnings report on Mar 25, 2026. Keep track of upcoming events with our Earnings Calendar.
1167 earnings for the last half-year are −0.09 HKD per share, whereas the estimation was −0.09 HKD, resulting in a 0.00% surprise. The estimated earnings for the next half-year are −0.12 HKD per share. See more details about Jacobio Pharmaceuticals Group Co., Ltd. earnings.
Jacobio Pharmaceuticals Group Co., Ltd. revenue for the last half-year amounts to 50.04 M HKD, despite the estimated figure of 50.04 M HKD. In the next half-year revenue is expected to reach 64.41 M HKD.
1167 net income for the last half-year is 14.48 M HKD, while the previous report showed −183.19 M HKD of net income which accounts for 107.90% change. Track more Jacobio Pharmaceuticals Group Co., Ltd. financial stats to get the full picture.
No, 1167 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 3, 2025, the company has 257 employees. See our rating of the largest employees — is Jacobio Pharmaceuticals Group Co., Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Jacobio Pharmaceuticals Group Co., Ltd. EBITDA is −207.05 M HKD, and current EBITDA margin is −122.71%. See more stats in Jacobio Pharmaceuticals Group Co., Ltd. financial statements.
Like other stocks, 1167 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Jacobio Pharmaceuticals Group Co., Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Jacobio Pharmaceuticals Group Co., Ltd. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Jacobio Pharmaceuticals Group Co., Ltd. stock shows the strong buy signal. See more of Jacobio Pharmaceuticals Group Co., Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.